News|Articles|September 7, 2022

COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 7, 2022

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

US COVID-19 vaccination & booster dose status

US COVID-19 vaccination status according to the Centers for Disease Control and Prevention (CDC) as of September 1, 2022, at 6:00 AM, EDT:

Fully vaccinated plus 2 booster doses:

• Aged ≥50 years 34%

• Aged ≥65 years 41.2%

Fully vaccinated plus 1 booster dose:

• Total US population 48.5%

Fully vaccinated in key age groups:

• Total US population 67.5%

• Aged ≥5 years 71.7%

• Aged ≥65 years 92.1%

US confirmed cases of COVID-19 and deaths

Confirmed US cases of COVID-19 and related deaths according to the Johns Hopkins COVID-19 interactive map, as of September 7, 2022 at 2:20 PM, EDT.

3 states with highest number of new cases in past 28 days

• California 283 781

• Texas 235 554

• Florida 167 190

• Total US confirmed cases 94 956 887

• Total US confirmed deaths 1 048 522

Global total COVID-19 confirmed cases, deaths, vaccine doses administered:

• Cases 606 658 877

• Deaths 6 507 002 • Vaccine doses administered 12 182 521 701

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

Latest CME

Multimedia

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

Neil M. Iyengar, MD; Komal Jhaveri, MD, FACP

Multimedia

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

Anil K. Agarwal, MD; Nissreen Elfadawy, MD, MSc, FASN

Multimedia

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 7, 2022

US COVID-19 vaccination & booster dose status

Fully vaccinated plus 2 booster doses:

• Aged ≥50 years 34%

• Aged ≥65 years 41.2%

Fully vaccinated plus 1 booster dose:

• Total US population 48.5%

Fully vaccinated in key age groups:

• Total US population 67.5%

• Aged ≥5 years 71.7%

• Aged ≥65 years 92.1%

US confirmed cases of COVID-19 and deaths

3 states with highest number of new cases in past 28 days

• California 283 781

• Texas 235 554

• Florida 167 190

• Total US confirmed cases 94 956 887

• Total US confirmed deaths 1 048 522

Global total COVID-19 confirmed cases, deaths, vaccine doses administered:

• Cases 606 658 877

• Deaths 6 507 002 • Vaccine doses administered 12 182 521 701

Newsletter

Related Content

FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause

Menopause: A Constellation of Syndromes Across 13 Body Systems

Marla Shapiro, CM‎, MDCM, on Recognizing Early Perimenopause: Sleep, Mood, and Other Missed Clues

Menopause Education Lags in Residency Training Across Primary Care Specialties

Timing of Menopausal Hormone Therapy May Impact Biomarkers of Alzheimer Disease

Latest CME

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Breast Cancer Symposia in San Antonio

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice

(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Evolving Strategies and Emerging Agents in PTCL: Subtypes, Mutations, and Modern Therapies

Rounds with Dr Jabbour: Breaking Barriers in ALL Treatment

Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

Community Practice Connections™: 21st Annual Meeting of the International Society of Gastrointestinal Oncology

Medical Crossfire®: Optimal Approaches to Evaluating and Addressing Pain in the Patient With Sickle Cell Disease

Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

Addressing Health Care Inequities™: Taking a More Mindful Approach to the Care of Every Patient Presenting With ATTR-CM

Clinical Case Vignette Series™: 3rd Annual International Congress on Pediatric Oncology

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Metastatic Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Ever-Evolving Treatment of MF, PV, and ET

From Barriers to Breakthroughs in Multiple Myeloma: How Trials Compare to the Real-World Management of Patients in Your Practice

Show Me the Data: How Do We Navigate the Latest Evidence on Novel Therapies and Trials Across GvHD Prophylaxis, Acute, and Chronic Care?

Show Me the Data™: Pushing CAR Ts Forward Across Lymphoid Malignancies…Accelerating Access in the Community and the Treatment Strategies for the Road Ahead

Medical Crossfire®: New Horizons in Acute Lymphoblastic Leukemia—How The Experts Apply New Evidence from AYA to Adult Scenarios

Real Psychiatry 2026

19th Annual New York GU Cancers Congress™

Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual Meeting

43rd Annual Miami Breast Cancer Conference®

17th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention